Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Equine Vet Sci ; 137: 105080, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38704000

ABSTRACT

A chemically defined cryopreservation extender that maintains seminal parameters is relevant. Fifteen ejaculates from 5 stallions (n= 5; r=3) were diluted in 5 extenders: 1) EDTA-glucose based extender with egg-yolk and dimethylformamide (EY); 2) commercial equine extender (CE); 3) CE with dimethylformamide (CE-3); 4) bovine commercial extender with liposomes (OP); 5) bovine commercial extender with soybean lecithin (BIO), and frozen using a slow and a rapid temperature descent curve. Post-thaw evaluations were: sperm kinematic parameters, viability and acrosome status, membrane lipoperoxidation and DNA fragmentation. Sperm data were analysed using an ANOVA or Friedman test (results mean ± SD). Paired comparison between the two freezing curves was analysed using the Wilcoxon test. Total and progressive motility were significantly higher (P<0.05) in the EY and CE-3 samples using the slow curve, whereas for the fast curve, total and progressive motility were significantly higher (P<0.05) in the EY samples compared to all the extenders and the samples frozen in CE-3 were significantly higher than the remaining extenders (P<0.05). The percentages of live acrosome intact sperm and of live non-peroxidized sperm were significantly higher (P<0.05) in the EY extender when using either of the freezing curves and in turn, were significantly higher (P<0.05) in samples frozen in CE-3 compared to the remaining extenders. Intact DNA was significantly lower (P<0.05) in the BIO extender, using the rapid curve. To conclude, the commercial equine extender with 3% dimethylformamide, without egg-yolk, could be a suitable alternative for extenders with egg-yolk.


Subject(s)
Cryopreservation , Cryoprotective Agents , Semen Preservation , Animals , Horses , Semen Preservation/methods , Semen Preservation/veterinary , Male , Cryopreservation/methods , Cryopreservation/veterinary , Cryoprotective Agents/pharmacology , Cryoprotective Agents/chemistry , Egg Yolk/chemistry , Spermatozoa/drug effects , Spermatozoa/physiology , Freezing , Sperm Motility/drug effects , Semen/drug effects , Semen/chemistry
2.
J Equine Vet Sci ; 136: 105069, 2024 May.
Article in English | MEDLINE | ID: mdl-38599258

ABSTRACT

The aim of this study was to evaluate two cryoprotectants, dimethylformamide (DMF) and methylformamide (MF) in two concentrations (5 and 7 %) in vitro in donkey semen using a rapid freezing technique and the effect on pregnancy rates in mares. Twenty-four ejaculates from 8 jacks (n = 8; r = 3) were divided into 4 extenders: BotuSemen Gold with 5 % or 7 % MF and 5 % or 7 % DMF, all containing 11 % lactose, 20 % egg-yolk and 0.5 % Equex. Post-thaw evaluations included: sperm motility, membrane function and acrosome status. A linear mixed effect model was used to test the effect of different freezing media on semen parameters. No differences were observed between the 4 freezing media used, for any of the seminal parameters (P > 0.05). However, samples with 5 % DMF showed the highest percentages of sperm with acrosomes and functional membranes (DMF: 5 %: 53.67 ± 22.01; 7 %: 33.92 ± 23.4; MF: 5 %: 44.5 ± 20.46; 7 %: 38.75 ± 27.4) (Data: mean ± SD; P > 0.05). Hence, thirty mares were inseminated: 15 with 5 % DMF and 15 with 7 % DMF. The pregnancy rate was 46 % (7/15) and 0 % (0/15) using the extender with 5 % or 7 % DMF, respectively (P = 0.003). To conclude, the use of 5 % or 7 % of MF or DMF did not affect the in vitro parameters. Despite the lack of differences in vitro with the two DMF concentrations, in vivo results only showed pregnancies when using 5 % DMF. Thus, the results of this study demonstrate the importance of accompanying in vitro semen evaluations with studies that evaluate post-insemination pregnancy rates.


Subject(s)
Cryopreservation , Cryoprotective Agents , Equidae , Semen Preservation , Animals , Equidae/physiology , Semen Preservation/veterinary , Semen Preservation/methods , Cryoprotective Agents/pharmacology , Female , Male , Cryopreservation/methods , Cryopreservation/veterinary , Pregnancy , Dimethylformamide/pharmacology , Insemination, Artificial/veterinary , Semen/drug effects , Semen/chemistry , Sperm Motility/drug effects , Formamides
3.
Virology ; 226(2): 260-8, 1996 Dec 15.
Article in English | MEDLINE | ID: mdl-8955046

ABSTRACT

A mutant human immunodeficiency virus (HIV-1) provirus encoding an envelope (Env) protein with a truncated transmembrane protein cytoplasmic domain was defective for replication. Coexpression of the mutant with a wild-type (wt) HIV-1 provirus potently inhibited the production of infectious virus. The maximum inhibitory effect was reached when the ratio of mutant to wt proviral DNA was 2:1. This transdominant defect in infectivity conferred by the mutant Env did not appear to involve the late steps of virus replication, since the synthesis, precursor processing, and intracellular transport of the Env proteins were not blocked; nor did it prevent the incorporation of the envelope proteins into virions or the subsequent release of the virus. Although the mutant Env protein still retained syncytia-forming ability, the truncated protein was unable to mediate cell-to-cell transmission of the virus. Moreover, coexpression with the mutant effectively inhibited the ability of the wt Env to mediate cell-to-cell transmission. The mutant Env protein formed a complex with the wt protein when they were coexpressed, producing heterooligomeric structures which appeared to be severely defective in an early, post-CD4 binding step of the virus life cycle despite the inclusion of wt Env in the complexes.


Subject(s)
Gene Products, env/genetics , HIV-1/genetics , Mutation , Animals , CD4-Positive T-Lymphocytes/virology , COS Cells , Cell Line , DNA, Viral/metabolism , Gene Products, env/physiology , Giant Cells/virology , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp120/physiology , HIV Envelope Protein gp41/genetics , HIV Envelope Protein gp41/physiology , HIV-1/pathogenicity , Humans , Proviruses/genetics , Proviruses/physiology , Transfection , Viral Interference , Virulence/genetics , Virus Replication/genetics , Virus Replication/physiology
4.
Proc Natl Acad Sci U S A ; 92(17): 7617-21, 1995 Aug 15.
Article in English | MEDLINE | ID: mdl-7644465

ABSTRACT

Although bacterial strain able to grow in the presence of organic solvents have been isolated, little is known about the mechanism of their resistance. In the present study, 1,2,3,4-tetrahydronaphthalene (tetralin), a solvent with potential applications in industrial biocatalysis, was used to select a resistant mutant of Escherichia coli. The resultant mutant strain was tested for resistance to a wide range of solvents of varying hydrophobicities and was found to be resistant not only to tetralin itself but also to cyclohexane, propylbenzene, and 1,2-dihydronaphthalene. A recombinant library from mutant DNA was used to clone the resistance gene. The sequence of the cloned locus was determined and found to match the sequence of the previously described alkylhydroperoxide reductase operon ahpCF. The mutation was localized to a substitution of valine for glycine at position 142 in the coding region of ahpC, which is the gene encoding the catalytic subunit of the enzyme. The ahpC mutant was found to have an activity that was three times that of the wild type in reducing tetralin hydroperoxide to 1,2,3,4-tetrahydro-1-naphthol. We conclude that the toxicity of such solvents as tetralin is caused by the formation of toxic hydroperoxides in the cell. The ahpC mutation increases the activity of the enzyme toward hydrophobic hydroperoxides, thereby conferring resistance. The ahpC mutant was sensitive to the more hydrophilic solvents xylene and toluene, suggesting that there are additional mechanisms of solvent toxicity. Mutants resistant to a mixture of xylene and tetralin were isolated from the ahpC mutant but not from the wild-type strain.


Subject(s)
Drug Resistance, Microbial/genetics , Escherichia coli/drug effects , Genes, Bacterial , Oxidoreductases/biosynthesis , Peroxidases , Solvents/pharmacology , Tetrahydronaphthalenes/pharmacology , Base Sequence , Chromosomes, Bacterial , Cloning, Molecular , DNA Primers , DNA, Bacterial/isolation & purification , DNA, Bacterial/metabolism , Escherichia coli/enzymology , Escherichia coli/growth & development , Escherichia coli Proteins , Kinetics , Molecular Sequence Data , Operon , Oxidoreductases/genetics , Peroxiredoxins , Polymerase Chain Reaction , Restriction Mapping , Sequence Deletion
5.
Gene ; 102(1): 143-4, 1991 Jun 15.
Article in English | MEDLINE | ID: mdl-1650732

ABSTRACT

IS402, a transposable gene-activating element isolated on the basis of its ability to increase expression of the Tn1 bla gene in Pseudomonas cepacia, was cloned from pTGL52 into the vector, pBluescript KS+, and its nucleotide (nt) sequence was determined. This 914-bp element had terminal inverted repeats of 17 bp with a single mismatch, and upon insertion into Tn1 generated a direct target duplication of 3 bp. Comparison of its nt sequence with the GenBank and EMBL databases indicated that IS402 is unrelated to previously described bacterial IS elements.


Subject(s)
DNA Transposable Elements/genetics , Pseudomonas/genetics , Base Sequence , Cloning, Molecular , Molecular Sequence Data , Repetitive Sequences, Nucleic Acid/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...